Manufacturing Chemist Stand Side with Syntegon

Published: 24-Jun-2024
Cell & Gene Therapy Contamination Control

Christian Lavarreda, Global Product Manager at Syntegon, speaks to Manufacturing Chemist

At ACHEMA 2024 in Frankfurt, Manufacturing Chemist spoke with Syntegon's Global Product Manager, Christian Lavarreda, to find out more about its novel modular bioprocessing platform, which can facilitate the simple and convenient routine maintenance and cleaning of a pharmaceutical cleanroom. 

Syntegon has also 'decluttered' the cleanroom space with its novel technology, as well as improving the ergonomics of the system.

Christian also explains the range of biopharmaceutical processes that can be facilitated by such a platform.

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

 

 

  • Companies:
  • Syntegon Technology
See more

You may also like

Manufacturing

Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development

Read more
Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil

Trending Articles

  1. Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil
  2. Recombinant versus synthetic peptide synthesis: the perks and drawbacks Since the introduction of novel peptide drugs into the market, the demand for polypeptide manufacturing has significantly increased, reports Dr Philipp Markolin
  3. Why CGT manufacturers should automate the production process Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient
  4. Why potency assays are a crucial consideration for CGT manufacturers Potency assays can enhance the efficiency of cell and gene therapy development and commercialisation while also bringing down costs
  5. Annex 1-compliant freeze drying: a technology supplier’s perspective Jessica Wagner, Validation Engineer at GEA, tells Dr Kevin Robinson how the company has embraced the updated version of Annex 1 and implemented the new changes. Key objectives were to remain compliant and demonstrate to their customers — both current and future — how the amends would be incorporated into ongoing or upcoming projects

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development

Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil
Manufacturing

Servier opens new €86m biologics production facility in Loiret, France

The company's Bio-S facility will be responsible for the production of biological medicines stemming from its R&D pipeline for preclinical and clinical studies
Digital

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient
Research & Development

Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics

Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions
Manufacturing

Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre

The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
Manufacturing

TrakCel to support cell and gene therapy orchestration with OCELLOS IT solution

The IT system allows cell and gene therapy (CGT) manufacturers to track the progress of personalised CGTs in real-time, while also managing their supply chain
Design & Build

Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies

Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
Subscribe now